ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Next Science Limited

Next Science Limited (NXS)

0.135
0.00
( 0.00% )
Updated: 15:27:49

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.135
Bid
0.135
Offer
0.145
Volume
199,052
0.135 Day's Range 0.14
0.115 52 Week Range 0.50
Market Cap
Previous Close
0.135
Open
0.135
Last Trade
979
@
0.135
Last Trade Time
15:27:49
Financial Volume
-
VWAP
-
Average Volume (3m)
201,203
Shares Outstanding
291,695,103
Dividend Yield
-
PE Ratio
-2.51
Earnings Per Share (EPS)
-0.06
Revenue
22.28M
Net Profit
-16.27M

About Next Science Limited

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Sydney, New South Wales, Aus
Founded
-
Next Science Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker NXS. The last closing price for Next Science was AUD0.14. Over the last year, Next Science shares have traded in a share price range of AUD 0.115 to AUD 0.50.

Next Science currently has 291,695,103 shares in issue. The market capitalisation of Next Science is AUD39.38 million. Next Science has a price to earnings ratio (PE ratio) of -2.51.

NXS Latest News

Next Science to Exhibit Surgical Product Portfolio at AAOS 2021

Next Science Limited (ASX:NXS), an innovative medical technology company, announced that it will exhibit at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting and conference in...

Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution

Highlights Clinical trial for XPERIENCE commences after receiving FDA clearance in April Randomized, controlled, double-blinded study will evaluate the effects of XPERIENCE in decreasing surgical...

Next Science Product Featured in Lifetime Channel Program on Treating Chronic Wounds

“The Balancing Act” segment will highlight how Next Science’s BLASTX® non-toxic, antimicrobial wound gel can help heal diabetic ulcers Next Science (ASX:NXS), an innovative medical technology...

Next Science’s XPERIENCE No Rinse Antimicrobial Solution Cleared by FDA for Sale in USA

Highlights XPERIENCE No Rinse Antimicrobial Solution receives FDA clearance XPERIENCE meets large unmet need – market leading performance in reduction of all tested pathogens Commercial sales in...

Next Science’s XPERIENCE No Rinse Antimicrobial Solution Cleared by FDA for Sale in USA

Highlights XPERIENCE No Rinse Antimicrobial Solution receives FDA clearance XPERIENCE meets large unmet need – market leading performance in reduction of all tested pathogens Commercial sales in...

Next Science and 3M Donate $300,000 of Breakthrough Wound Treatment to Jacksonville-Area Charity

New BlastX donation reaffirms the company’s commitment to healthcare nonprofits and their patients suffering from chronic wounds Next Science (ASX:NXS), an innovative medical technology company...

Next Science and 3M Donate $300,000 of Breakthrough Wound Treatment to New Jersey Nursing Care Facility

Blast X donation is one of several to long-term care facilities to effectively treat chronic wounds Next Science (ASX:NXS), an innovative medical technology company that is the leader in...

UPDATE: Senior Woodside Executive Leaves For Nexus Energy

Woodside Petroleum Ltd. (WPL.AU) has lost its third senior staffer since it changed chief executives last year, with the head of its flagship Pluto gas-export project Lucio Della Martina leaving...

Nexus Says Companies Eyeing Crux Stake; Writes Down Longtom

Nexus Energy Ltd. (NXS.AU) on Wednesday said several large companies have expressed interest in buying part of its share of the Crux gas and liquids joint venture with Royal Dutch Shell PLC (RDSB...

Nexus Energy CEO Expects Crux Equity Selldown In 4-6 Weeks

Nexus Energy Ltd. (NXS.AU) is poised to sell down a stake in its Crux liquids project offshore Western Australia state by next month ahead of officially approving construction of the A$1.78...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.005-3.571428571430.140.1450.1351371880.13892995DE
4-0.005-3.571428571430.140.170.132098890.14385555DE
12-0.085-38.63636363640.220.250.1152012030.15154831DE
26-0.11-44.89795918370.2450.3050.1151739150.1946658DE
52-0.145-51.78571428570.280.50.1151636680.25177418DE
156-1.14-89.41176470591.2751.330.1151362650.46069376DE
260-2.375-94.62151394422.512.760.1151545730.95185665DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PAROParadigm Biopharmaceuticals Limited
AUD 0.003
(200.00%)
3.08M
CDECodeifai Ltd
AUD 0.002
(100.00%)
2.05M
LVHLiveHire Limited
AUD 0.0455
(68.52%)
26.62M
PARParadigm Biopharmaceuticals Ltd
AUD 0.49
(50.77%)
7.36M
MTLMantle Minerals Limited
AUD 0.0015
(50.00%)
1.18M
CCLCoca Cola Amatil Limited
AUD 2.295
(-82.74%)
2.3M
EM2OEagle Mountain Mining Limited
AUD 0.002
(-60.00%)
1.44M
EM2Eagle Mountain Mining Limited
AUD 0.019
(-51.28%)
15.9M
YRLYandal Resources Limited
AUD 0.2225
(-40.67%)
7.72M
FG1OFlynn Gold Limited
AUD 0.005
(-37.50%)
18.75k
SP8StreamPlay Studio Ltd
AUD 0.015
(25.00%)
68.38M
NRZNeuRizer Ltd
AUD 0.002
(0.00%)
66.12M
OVTOvanti Ltd
AUD 0.024
(0.00%)
42.96M
BTRBrightstar Resources Limited
AUD 0.026
(13.04%)
42.46M
MTBMount Burgess Mining Nl
AUD 0.001
(0.00%)
42.38M

Discussion

View Full Feed
MrMike241 MrMike241 9 minutes ago
This makes it clear. Very interesting. The cork allows for a tiny amount of oxygen over time, from the cork itself (not through it), which is good for some reds, only. And always bad for whites. Yes, some air does enter the wine from the cork, but not through the cork.
https://www.decanterc
chklingon chklingon 9 minutes ago
I was just going to post this. Thanks for bring it to the board! 👍️
TSLA
lakers17 lakers17 12 minutes ago
It will all be over for NSAV this week or next. Bankruptcy or expert market coming. Lawyer gone who they haven't paid. NSAV is done and broke. Judge is going to come down hard on Tilton and NSAV. Clear as day. The judge hates Tilton. He will represent NSAV in the next hearing? 🤣ǹ
NSAV
elks elks 15 minutes ago
We have a new crow in town
RDAR
dewophile dewophile 15 minutes ago
It’s a clear and rather surprising miss by the market. Even a small chance of liability years away should have elicited *some* reaction. But the market has been weird when it comes to this stuff it seems. Zantac for example didn’t affect companies much until the litigation moved further along and t
dinogreeves dinogreeves 16 minutes ago
Reddit comments on CV*NA. Telling you all, this is the next CV*NA but it will be a lot faster and furious.

https://www.reddit.com/r/wallstreetbets/comments/1e456ww/cvna_its_a_short_dont_act_like_i_never_told_ya/?rdt=59586
SMCI
cryptopunks cryptopunks 18 minutes ago
Probably for good reason. RS announcements are bad news.
IONI
Konaploinks Konaploinks 20 minutes ago
L
IONQ
Konaploinks Konaploinks 20 minutes ago
Let the takeover wars begin.
IONQ
tmcfo tmcfo 21 minutes ago
Where do you think those 20 people work for?
MVNT
leverage102 leverage102 22 minutes ago
Illinois, a default judgment can be vacated within 30 days by filing a written motion with the court. The motion must be sent to the other party in the case, and the filer must appear in court for a hearing. The trial court has the discretion to grant or deny the motion.

Approved - Or
NSAV
tmcfo tmcfo 25 minutes ago
Those sites are not reliable, they are all over the place. If you believe that “gentleman” that there were 20 people working, then it cant’t be Mvnt since those costs are not showing anywhere in mvnt financials. My only guess is they are under Velocity, not sure where else can they be. Unless, L
MVNT
Jim Beem Jim Beem 26 minutes ago
SEC DELINQUENT NOTICE ON ASII
ASII
BDEZ BDEZ 28 minutes ago
For sure!
georgejjl georgejjl 29 minutes ago
News that is IMMINENT

A lot of news to be expected prior to the end of the year 2024

Alzheimer’s disease: Data from the blarcamesine Phase 2b/3 ANAVEX®2-73-AD-004 trial to be published in an upcoming peer-reviewed journal

Alzheimer’s disease: Full reg
AVXL
stockhero stockhero 33 minutes ago
I've been trying to buy pizza and subs for the past 10 years.
GMPR
tredenwater2 tredenwater2 33 minutes ago
“ I agree, crescent, that the announcement this evening is quite unusual.”

Its quite a bit different than last time they released data by releasing their past trial data twice, one week apart. The first time the stock wd t absolutely nowhere. The second time they released it the stock
AVXL
north40000 north40000 33 minutes ago
Paid full price for Brand Vascepa last time(after 7/01/2024). 

Typo: There is a patent infringement suit in Delaware, not yet an antitrust suit there.
AMRN
3331 3331 35 minutes ago
BIEL (Bioelectronics): #5 BREAKOUT BOARD + #5 MOST READ (last hour)!
blackhawks blackhawks 35 minutes ago
Hey Trump Voters .........

https://i.postimg.cc/sxY6Q0K0/IMG-4787.jpg

Your Recent History

Delayed Upgrade Clock